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New CMS Guidance on Medicare Part D Creditable Coverage Notice Offers 
Helpful Direction for Prescription Drug Plan Sponsors 
 




As part of the continuing onslaught of regulatory guidance from the Centers for Medicare 
and Medicaid Services (“CMS”) in advance of the January 1, 2006 introduction of the 
new Medicare Part D prescription drug benefit, CMS in late May issued welcome 
clarification of the creditable coverage notice requirements for plans that currently 
provide prescription drug coverage to Medicare beneficiaries.1  The guidance is 
accompanied by model notices that entities (other than Medigap insurers) may use to 
satisfy the notice requirements.2  Although some businesses may take issue with various 
aspects of the guidance and the model notices, CMS has nonetheless resolved a number 
of issues for organizations that sponsor prescription drug plans and are struggling to 
restructure their programs in light of Medicare Part D. 
 
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the 
“MMA”) added the new Part D to Medicare to offer a basic outpatient prescription drug 
benefit to Medicare beneficiaries beginning January 1, 2006.3  The MMA provides for an 
initial enrollment period for Medicare Part D eligible beneficiaries, beginning November 
15, 2005 and ending May 15, 2006.4  To push Medicare beneficiaries to move into the 
new Part D, the MMA imposes a late enrollment penalty on any eligible individual who 
fails to enroll in Part D unless the individual “maintain[s] continuous creditable 
prescription drug coverage during the period of non-enrollment.”5  After the initial 
enrollment period ends, an eligible individual is subject to the late enrollment penalty if 
he or she has a period of 63 days or longer without enrollment in either Part D or other 
creditable coverage, then enrolls in Part D.6  The late enrollment penalty is calculated 
based on the number of months during which an eligible individual was neither enrolled 
in Part D nor otherwise enrolled in creditable coverage and is at least one percent of the 
                                                 
1 United States Department of Health and Human Services, Centers for Medicare & Medicaid Services 
[hereinafter CMS], Creditable Coverage Guidance, at 
http://www.cms.hhs.gov/medicarereform/CCGuidance.pdf (last visited June 29, 2005) [hereinafter 
Guidance]. 
2 CMS, Model Beneficiary Non-Creditable Coverage Disclosure Language For Use Prior To 11/15/05, at 
http://www.cms.hhs.gov/medicarereform/Non-CredCov-BeneDsclsreNtc.pdf (last visited June 29, 2005) 
and Model Beneficiary Creditable Coverage Disclosure Language For Use Prior To 11/15/05, at 
http://www.cms.hhs.gov/medicarereform/CredCov-BeneDsclsreNtc.pdf (last visited June 29, 2005) 
[hereinafter Model Notices].  
3 Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Pub. L. No. 108-173, 117 
Stat. 2006 (2003). 
4 S.S.A. § 1860D-1(b)(2)(A), 42 U.S.C. § 1395w-101(b)(2)(A); S.S.A. § 1851(e)(3)(B), 42 U.S.C. § 
1395w-21(e)(3)(B). 
5 S.S.A. § 1860D-1(b)(6)(B), 42 U.S.C. § 1395w-101(b)(6)(B); S.S.A. § 1860D-13, 42 U.S.C. § 1395w-
113. 
6 42 C.F.R. § 423.46 (2005). 
monthly base beneficiary Part D premium.7  Not only will the penalty never expire, but 
CMS notes that the higher premium (due to the late enrollment penalty) will “actually 
increase each year” because the late enrollment penalty is calculated as a percentage of 
the base premium, which is expected to increase each year.8  
 
Medicare Part D “creditable coverage” includes coverage under a Part D prescription 
drug plan, a Medicare Advantage (formerly Medicare+Choice) prescription drug plan, an 
employer group health plan (including a retiree prescription drug plan), certain military 
and veterans’ prescription drug programs, coverage under Medigap policies, and 
coverage under state pharmaceutical assistance plans,9 provided that the coverage meets 
an actuarial equivalence requirement specified in the MMA.10  The MMA considers 
prescription drug coverage as “creditable coverage” only if the value of the coverage is at 
least actuarially equal to the value of the standard Part D prescription drug benefit.11 
 
For a Part D eligible individual who otherwise has prescription drug coverage that will 
continue after Part D becomes effective, understanding how that coverage compares to 
the Part D standard benefit and the various alternatives available under Part D (including 
enrollment in a Medicare Advantage plan that includes prescription drug coverage) will 
be critical to effective decision-making.  If the individual’s existing prescription drug 
coverage qualifies as creditable coverage, the individual should still evaluate whether a 
Medicare Part D option offers more valuable coverage for that individual (for example, 
due to a different drug formulary or different co-pay structure).  If the individual’s 
existing prescription drug coverage does not qualify as creditable coverage and the 
individual fails to switch to Part D coverage during the initial Part D enrollment period, 
the individual will be permanently injured financially by the Part D late enrollment fee. 
 
To aid individuals in understanding their options, the MMA mandates disclosure by 
entities offering prescription drug coverage (other than Medicare Part D coverage) of 
whether or not their coverage qualifies as creditable coverage, as well as information 
about the consequences of failing to enroll in Part D for an individual with coverage that 
does not qualify as creditable coverage.12  CMS’ May guidance focuses on this disclosure 
and provides far more detail than is available in either the MMA or the related 
regulations. 
 
In general, the May guidance clarifies that the determination of creditable coverage for 
purposes of the required disclosure does not require an attestation by a qualified actuary 
(unless the prescription drug plan is an employer or union plan attempting to qualify for 
the MMA’s employer plan subsidy).13  The guidance also provides a safe harbor plan 
design that qualifies as creditable coverage.14  Finally, the guidance provides details of 
                                                 
7 S.S.A. § 1860D-13(b)(3)(A), 42 U.S.C. § 1395w-113(b)(3)(A). 
8 CMS, Guidance, supra note 1. 
9 S.S.A. § 1860D-13(b)(4), 42 U.S.C. § 1395w-113(b)(4). 
10 S.S.A. § 1860D-13(b)(5), 42 U.S.C. § 1395w-113(b)(5). 
11 Id. 
12 S.S.A. § 1860D-13(b)(6)(B), 42 U.S.C. § 1395w-113(b)(6)(B). 
13 CMS, Guidance, supra note 1. 
14 Id. 
 2
what the disclosure to eligible beneficiaries should contain, both for individuals in plans 
that offer creditable coverage and for individuals in plans with coverage that fails to 
qualify as creditable, and clarifies acceptable methods of distributing the notices to 
eligible individuals.15  As part of the latter piece of guidance, CMS has posted model 
notices on its website.16 
 
Industry commentators have already noted various drawbacks to the guidance.  For 
example, some employers may feel the model notices “raise more questions than they 
answer”17 or are “too confusing or misleading to give to their plan participants.”18  
Because the CMS requirements for electronic delivery of the disclosure notices (model or 
otherwise) differ from – and appear to be more demanding than – the requirements 
applicable to other types of employee communications (particularly the Department of 
Labor’s requirements for notices under the Employee Retirement Income Security Act), 
employers may find it difficult to comply and be forced to mail notices.19  For employers 
who have already planned their benefit communications strategies for the year, the 
guidance may be perceived as coming late and disrupting communications plans.20  
Employers who had already begun drafting disclosure notices based on the regulations 
and previous guidance may find that they must revise those drafts to reflect the details 
required by CMS, even if they choose not to adopt the model notices.   
 
On the other hand, for organizations – particularly employers who sponsor retiree 
prescription drug plans – that have been waiting to design their communications to plan 
participants, the CMS guidance cannot help but be useful.  At the very least, it settles any 
questions as to what will satisfy CMS and lays to rest concerns that an expensive 
actuarial attestation is required even if a plan sponsor does not plan to pursue the MMA’s 
employer subsidy.  As the months wane until Medicare Part D goes into effect, every bit 
of assistance from CMS that clarifies previously unresolved issues should be perceived as 
fundamentally useful.  
                                                 
15 Id. 
16 CMS, Model Notices, supra note 2. 
17 McDermott Will & Emery, Group Health Plan Sponsors Required to Send New Medicare Notice (June 
17, 2005), at http://mwe.com//fuseaction/publications.nldetail_print [hereinafter Comments].   
18 Aon Consulting, Alert: Medicare Part D “Creditable Coverage” Model Notices Released (May 31, 
2005), at http://www.aon.com/about/publications/pdf/alert/alert_05_31_05.pdf.  
19 McDermott, Comments, supra note 17.  See also Hewitt Associates, Medicare Part D Creditable 
Coverage Guidance Issued by CMS (June 2005), at http://was4.hewitt.com/hewitt/resource/legislative_ 
updates/united_states/pdfs/creditable_coverage_guidance.pdf. 
20 McDermott, Comments, supra note 17. 
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